Featured Research

from universities, journals, and other organizations

Innovative system for the rehabilitation of people with brain damage

Date:
January 9, 2013
Source:
Asociación RUVID
Summary:
Scientists are developing an innovative rehabilitation system to improve the quality of life of people who have suffered brain damage. This system will allow home rehabilitation and improve patient’s autonomy.

Preclinical testing to validate the prototype.
Credit: Image courtesy of Asociación RUVID

The Biomechanics Institute of Valencia (IBV) is currently taking part in the European project WALKX with the aim of developing an innovative rehabilitation system to improve the quality of life of people who have suffered brain damage. This system will allow home rehabilitation and improve patient's autonomy.

WALKX is a two-year research project for the benefit of small and medium sized enterprises (SMEs), co-funded by the European Commission through the Seventh Framework Programme.

The user friendly walking training device the partners are designing will support the patient in raising from sitting to standing position and enable the patient to perform walking training and improve his/her manoeuvrability. "An upper body stabilizing and controllable supporting vest will be developed. Early in the rehabilitation process it will be used under supervision of a therapist, but with greatly reduced need for physical support from the therapists. This is intended to reduce the need for help from others and increase freedom of movement and personal autonomy of the patient," said Ignacio Bermejo, Market Innovation Director at IBV.

One of the novelties of this device consists of a vest with attachment points on the patient's waist in order to regulate the mobility of the trunk. Also, the device will be modular and low cost. The role of IBV in this initiative has been to define the design specifications and preclinical testing to validate the prototype. Preclinical tests are done in collaboration with the Department of Physical Medicine and Rehabilitation at the Hospital Universitari i Politčcnic La Fe of Valencia.

The project is coordinated by the Norwegian company Made for Movement Group. Besides Biomechanics Institute, other members of the consortium are Innovatsiooni Eesti Instituut (Estonia), INNORA ROBOTICS (Greece), Newtrim and MCT (UK), ENIX (France), Motus (Italy) and MOBILE ROBOTICS SWEDEN (Sweden).

Stroke (cerebrovascular accident) is the most common cause of adult disability in Europe. Roughly 75% of victims survive, but about half of these lose the ability to live independently in their own home. As strokes often result in long term disability rather than death, the rehabilitation and hospitalisation represent a major economic burden for the EU of about €34 Bn annually. Currently, the annual incidence is approximately 2 per 1,000 inhabitants in the EU, and the number is predicted to double over the next 50 years due to the aging of the population.


Story Source:

The above story is based on materials provided by Asociación RUVID. Note: Materials may be edited for content and length.


Cite This Page:

Asociación RUVID. "Innovative system for the rehabilitation of people with brain damage." ScienceDaily. ScienceDaily, 9 January 2013. <www.sciencedaily.com/releases/2013/01/130109081143.htm>.
Asociación RUVID. (2013, January 9). Innovative system for the rehabilitation of people with brain damage. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/01/130109081143.htm
Asociación RUVID. "Innovative system for the rehabilitation of people with brain damage." ScienceDaily. www.sciencedaily.com/releases/2013/01/130109081143.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins